Literature DB >> 2209677

Epilepsy in multiple sclerosis.

A Ghezzi1, R Montanini, P F Basso, M Zaffaroni, E Massimo, C L Cazzullo.   

Abstract

In a series of 2,353 multiple sclerosis (MS) patients, 40 subjects presented seizures, with an overall prevalence of 1.70%. The prevalence was 2.33% (34/1,459) in definite MS cases, 0.58 in probable cases (3/518), 0.79 in possible cases (3/376). Twenty-six patients were females, 14 were males. In 13 cases, epilepsy had begun before MS onset; in 4 patients, the two diseases started contemporarily; in 23 patients, epilepsy followed MS onset. No relationship was found between frequency of seizures and course of MS nor between frequency of seizures and MS severity. In 12 patients, magnetic resonance imaging was performed: plaques adjacent to the cerebral cortex were found in 3 cases. The electroencephalogram showed paroxysmal discharges in 11 patients (focal in 2, diffuse in 9). Slow theta and/or delta activity was found in 15 patients (focal in 7, diffuse in 6, both focal and diffuse in 2). The EEG was normal in 14 patients. Possible etiological factors other than MS were recognized in 4 patients only: cranial trauma in 3, meningitis in 1. Our study on a large MS population confirms that MS is associated to a risk for epilepsy higher than that of the general population.

Entities:  

Mesh:

Year:  1990        PMID: 2209677     DOI: 10.1159/000117350

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  16 in total

1.  Chronic demyelination-induced seizures.

Authors:  Andrew S Lapato; Jenny I Szu; Jonathan P C Hasselmann; Anna J Khalaj; Devin K Binder; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2017-01-30       Impact factor: 3.590

Review 2.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

3.  Inflammatory Demyelinating Diseases of Childhood: Case Report and Literature Review.

Authors:  Esme Ekizoğlu; Pınar Tektürk Topaloğlu; Zuhal Yapici; Mefkûre Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

Review 4.  Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Michele Ascoli; Chiara Sueri; Vittoria Cianci; Concetta Russo; Laura Rosa Pisani; Pasquale Striano; Maurizio Elia; Ettore Beghi; Carmela Colica; Umberto Aguglia
Journal:  Neurol Sci       Date:  2017-01-04       Impact factor: 3.307

Review 5.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 6.  Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.

Authors:  R T Schapiro
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

7.  Seizures due to multiple sclerosis: seven patients with MRI correlations.

Authors:  A J Thompson; A G Kermode; I F Moseley; D G MacManus; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

Review 8.  Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.

Authors:  Sahil Gupta; Irfan Ahsan; Naeem Mahfooz; Noureldin Abdelhamid; Murali Ramanathan; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

9.  Extensive cortical inflammation is associated with epilepsy in multiple sclerosis.

Authors:  Massimiliano Calabrese; Nicola De Stefano; Matteo Atzori; Valentina Bernardi; Irene Mattisi; Luigi Barachino; Luciano Rinaldi; Aldo Morra; Matthew M J McAuliffe; Paola Perini; Leontino Battistin; Paolo Gallo
Journal:  J Neurol       Date:  2008-01-31       Impact factor: 4.849

Review 10.  Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Omid Mirmosayyeb; Vahid Shaygannejad; Nasim Nehzat; Aida Mohammadi; Mahsa Ghajarzadeh
Journal:  Int J Prev Med       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.